Lataa...
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle
The combined loss of muscle strength and constant fatigue are disabling symptoms for cancer patients undergoing chemotherapy. Doxorubicin, a standard chemotherapy drug used in the clinic, causes skeletal muscle dysfunction and premature fatigue along with an increase in reactive oxygen species (ROS)...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3859698/ https://ncbi.nlm.nih.gov/pubmed/24017970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.freeradbiomed.2013.08.191 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|